Fig. 5From: Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastomaReprinted with permission from [129]; copyright (2021) Elsevier Ltd.Iron oxide NPs for MRI ang NIR-II FI. NIR-II FI of the orthotopic GBM models after tail intravenous injection of a CH4T@MOF-PEG-AE or b CH4T@MOF-PEG-SCM. c T2WI and the corresponding MRI signal values before and after CH4T@MOF-PEG-AE treatment. d Thermal images of PBS group and CH4T@MOF-PEG-AE group in ten minutes. e Tumor weight in different treatment.Back to article page